WHO Approves Sinopharm COVID Vaccine From China

• The World Health Organization has announced the approval of the Sinopharm COVID vaccine from China

• The newly released vaccine is reported to have 79% efficacy against COVID 19

• This will be the second vaccine released by china since the pandemic, following the release of the Sinovac vaccine

The World Health Organization (WHO) has announced the approval of a vaccine from China- the Sinopharm COVID vaccine.

This is the first vaccine that is developed by a non-western country that gets the organization’s backing.

Before this, WHO had only approved Pfizer, AstraZeneca, Moderna, Johnson & Johnson.

The Sinopharm vaccine has an efficacy of 79% against COVID 19.

Poorer countries in Africa, America, and Asia have also approved the vaccine for emergency use.

WHO claims that the newly released vaccine can help increase vaccine access and limit the spread of coronavirus.

It is recommended that the vaccine be administered to those above the ages of 18.

Read also: Nigeria Bans Travelers from India, Brazil, and Turkey

WHO is also currently assessing the Russian developed vaccine, Sputnik and it may be approved in the coming days.

Follow Naija.fm on our social media handles Facebook, Instagram, and Twitter to keep up with trending news, breaking news, entertainment news, and hot gist.